Background-Presently, no effective risk model exists to predict long-term mortality or other major adverse cardiovascular and cerebrovascular events (MACCE) in those patients undergoing percutaneous coronary intervention (PCI). This study aimed to assess whether the Clinical SYNTAX Score (CSS) calculated by multiplying the SYNTAX Score to a modified ACEF score (age/ejection fraction ϩ1 for each 10 mL the creatinine clearance Ͻ60 mL/min per 1.73 m
C oronary artery bypass grafting (CABG) has historically been the preferred method of revascularization in patients with complex coronary artery disease (CAD); however, recent evidence indicates that in specific groups of patients, percutaneous coronary intervention (PCI) can offer a safe and suitable alternative. [1] [2] [3] [4] This expanding use of PCI 5 has consequently increased the importance of developing a systematic approach for risk stratifying these complex patients so that they might receive the appropriate revascularization option. The ability to objectively decide which patients with complex CAD are suitable for PCI has gained new ground recently after the introduction of the SYNTAX Score. 6, 7 Not only can this lesion-based scoring system quantify coronary anatomic complexity, but studies also demonstrate that it has a role in the short-and long-term risk stratification of patients undergoing PCI. 1,4,8 -11 
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One of the limitations of using the SYNTAX Score in this context is that lesion-based scoring systems have been shown to have a lower ability to predict mortality when compared with scoring systems using clinical characteristics. 12 In patients undergoing PCI, there are currently only limited data available on the use of risk scores that rely solely on clinical characteristics, such as the euroSCORE. [13] [14] [15] Moreover, it has been suggested that the use of too many individual variables may reduce the overall accuracy of data. 16 The recently introduced ACEF score, for example, uses just age, left ventricular ejection fraction (LVEF), and serum creatinine (SCr) and appears to be as good as more complex scores in predicting mortality in patients undergoing elective CABG. 17 An acceptable modification to the ACEF score is to use the derived creatinine clearance (CrCl) instead of SCr because this not only represents a better estimate of underlying renal function but has also been previously shown to improve the predictive accuracy of cardiac risk models such as the euroSCORE. 18 The aim of this study was to investigate whether a Clinical SYNTAX Score (CSS), representing a multiplication of the SYNTAX score with a modified ACEF score (through the incorporation of CrCl), would improve the individual ability of either of these scores to predict mortality in patients with complex CAD undergoing PCI, who were enrolled in the Arterial Revascularization Therapies Study Part II (ARTS-II).
Methods

Study Population
The ARTS-II study has been published previously. 19 In brief, the study was a multicenter, nonrandomized, open-label trial designed to compare the safety and efficacy of the sirolimus eluting stent (SES) in 607 patients with de novo multivessel CAD, using the surgical group of ARTS-I as historic controls.
Patient Selection
Patients with stable angina, unstable angina, or silent ischemia, who had Ն2 coronary lesions located in different major epicardial vessels and/or their side branches (not including the left main stem [LMS] ) that were potentially amenable to stent implantation, were eligible for inclusion. All patients enrolled into the ARTS-II study were required to have a lesion with a diameter stenosis Ͼ50% in the left anterior descending artery and Ն1 other major epicardial coronary artery.
The goal was to achieve complete anatomic revascularization. Coronary lesions were required to be amenable to stenting using a SES with a diameter of 2.5 to 3.5 mm and length of 13 to 33 mm; there was no restriction on the total implanted stent length. Decisions to place stents in lesions with bifurcations, fresh thrombus, calcification, diffuse disease, complex anatomy, or stenting of side branches were left to the discretion of the operators.
The major exclusion criteria were patients with previous PCI, LMS disease, overt congestive heart failure, LVEF Ͻ30%, history of a cerebrovascular accident, transmural myocardial infarction (MI) in the preceding week, severe hepatic or renal disease, neutropenia or thrombocytopenia, an intolerance or contraindication to acetylsalicylic acid or thienopyridines, the need for concomitant major surgery, and life-limiting major concomitant noncardiac diseases. Written informed consent was obtained from each patient prior to enrolment, and the study was approved by the ethics committee of each participating site.
Clinical SYNTAX Score
The CSS was calculated retrospectively for each patient using the formula CSSϭ[SYNTAX Score]ϫ[modified ACEF score].
The SYNTAX Score for each patient was calculated retrospectively by scoring all coronary lesions with a diameter stenosis Ն50%, in vessels Ն1.5 mm, using the SYNTAX Score algorithm, which is described in full elsewhere 6, 7 and is available on the SYNTAX Score website (www.syntaxscore.com). All angiographic variables pertinent to SYNTAX Score calculation were computed by blinded core laboratory analysts (Cardialysis B.V., Rotterdam, The Netherlands).
The modified ACEF score (ACEF CrCl ) was calculated retrospectively using the formula age/ejection fraction ϩ1 point for every 10 mL/min reduction in CrCl below 60 mL/min per 1.73 m 2 (up to a maximum of 6 points). Therefore, a CrCl of between 50 to 59 mL/min per 1.73 m 2 , 40 to 49 mL/min per 1.73 m 2 and 30 to 39 mL/min per 1.73 m 2 would receive 1, 2, and 3 points, respectively. The LVEF used was the value recorded before the index PCI, and in the event of multiple available values was the lowest recorded figure.
Creatinine clearance was calculated using the Cockcroft-Gault equation, 20 using the patient's age, weight, and SCr recorded before the index PCI.
Presently, the only published prospective validation of the SYN-TAX score comes from the SYNTAX trial. 1 This study only enrolled patients with complex CAD (3-vessel disease [3VD] and/or LMS), and, in view of this, analysis of the CSS in patients who only had treatment for 3VD is shown in an online Data Supplement. For comparison, additional analyses in patients with 3VD have also been performed using the CSS calculated using the standard ACEF score (ie, using SCr, [ACEF SCr ]); the SYNTAX score combined by multiplication with the additive euroSCORE (EURO ADD ) and logistic euroSCORE (EURO LOG ); and the Mayo Clinic Risk Score (MCRS); these can all be found in the online Data Supplement.
End Points
The primary end point of this post hoc study was mortality at 1-year follow-up. The secondary end points were major adverse cardiovascular events (MACCE), defined as a composite of death, cerebrovascular accident, any revascularization (percutaneous or surgical), and MI at 1-and 5-year follow-up.
Definitions
Deaths included mortality from any cause. Cerebrovascular accidents included transient ischemic attacks, reversible neurological deficits, intracranial hemorrhage, and ischemic stroke. 21 MI was defined in the first 7 days after the intervention, if there was documentation of new abnormal Q waves and either a ratio of serum creatinine kinase MB (CK-MB) isoenzyme to total creatinine kinase (CK) that was Ն0.1, or a CK-MB value that was 5 times the upper limit of normal. Serum CK and CK-MB isoenzyme concentrations were measured 6, 12, and 18 hours after the intervention. Commencing 8 days after the intervention (the length of the hospital stay after surgery), either abnormal Q waves or enzymatic changes were sufficient for a diagnosis of MI. An MI was only confirmed after the relevant ECGs had been analyzed by the core laboratory and adjudicated by the clinical events committee. This 2-part method of defining MI was developed for ARTS-I to address the difficulty in diagnosing an MI after cardiac surgery. 21 These definitions have been adopted by the ARC Consortium and are applied whenever a comparison between PCI and coronary artery surgery is performed. In the final report, the window of 7 days is not specifically mentioned, and this window has been maintained for the sake of comparison with the historical data from ARTS-I.
Statistical Methods
All variables were stratified according to CSS tertiles. Continuous variables are expressed as meanϮ SD and were compared using 1-way ANOVA. Categorical data are presented as frequency (percentages) and were compared using the Fisher exact test or the Pearson 2 test. The distribution of the SYNTAX Score, ACEF SCr score, and CSS were assessed before and after logarithmic transformation using the Kolmogorov-Smirnov test. Clinical outcomes are presented as hierarchical and nonhierarchical outcomes, with the hierarchical outcomes only reporting the worst outcome (following the order death, stroke, MI [Q-wave, followed by non-Q-wave], and repeat revascularization [CABG then PCI]) that the patient experiences. Survival curves were constructed for time-to-event variables using Kaplan-Meier estimates and compared by the log-rank test. Patients lost to follow-up were considered at risk until the date of last contact, at which point they were censored. Cox regression analysis was used to find independent predictors of MACCE, with those variables with a probability value of Ͻ0.10 in the univariate analysis being included in the backward stepwise multivariable model. Receiver operator curves (ROC) were used to compare the performance and predictive accuracy of the CSS, SYNTAX Score, ACEF SCr, ACEF CrCl, EURO ADD , EURO LOG , MCRS, and the SYNTAX score combined with the euroSCORE (additive and logistic) for MACCE and mortality at 5-year follow-up. A probability value of Ͻ0.05 was considered significant, and all tests were 2-tailed. Data were analyzed with SPSS version 17.0 software (SPSS Inc, Chicago, Ill).
Results
The ARTS-II study recruited 607 patients, of whom 512 (84.3%) had 2-or 3-vessel intervention at the time of the index PCI and had LVEF, SCr, and body weight recorded at baseline. Median (interquartile range, IQR) follow-up was 1800 (IQR, 0) days. The results of analyses performed in the 239 (39.3%) patients in the ARTS-II study who had treatment for only 3VD and had LVEF, SCr, and body weight recorded at baseline are shown in the online Data Supplement.
SYNTAX, ACEF SCr , and CSS Scores
The SYNTAX Score ranged from 4 to 58, with a meanϮ SD of 20.8Ϯ9.6 and a median of 19 (IQR, 11.9). The ACEF SCr score ranged from 0.5 to 2.3, with a meanϮ SD of 1.07Ϯ0.27 and a median of 1.1 (IQRϭ0.3). The CSS ranged from 4 to 209, with a meanϮ SD of 27.2Ϯ23.8, and a median of 20.5 (IQRϭ18.7). All 3 scores were initially nonparametric (Kolmogorov-Smirnov test, PϽ0.05) and became normally distributed after logarithmic transformation (Supplementary Figure 1) .
In this post hoc analysis, the 512 patients (1645 treated lesions) were divided according to their CSS into tertiles defined as CSS LOW Յ15.6 (nϭ170), 15.6ՅCSS MID Ͻ27.5 (nϭ171), and CSS HIGH Ͼ27.5 (nϭ171).
Baseline Angiographic and Procedural Characteristics
Baseline angiographic and procedural characteristics of the study population, stratified according to CSS tertiles, are shown in Tables 1 and 2 . Patient age and hypertension were both significantly higher in the CSS HIGH tertile, whereas body mass index, family history of CAD, current smoking, and CrCl were all significantly lower in the CSS HIGH . Table 2 demonstrates that indicators of lesion complexity, such as lesion length and lesion type, were significantly greater in the CSS HIGH tertile, reflecting the higher calculated SYNTAX Score for these lesions.
Outcomes at 12 Months
Hierarchical and nonhierarchical clinical outcomes at 12 months are shown in Figure 1 demonstrates the rates of death, MI, repeat revascularization, and MACCE according to CSS tertiles during 
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The Clinical SYNTAX Scorelong-term follow-up. There were no significant differences in events (death/MI/repeat revascularization/MACCE) between patients in the low and mid CSS tertiles. Patients in the CSS HIGH tertile had significantly higher rates of repeat revascularization and MACCE when compared with the lower 2 tertiles. In addition, mortality was significantly higher with CSS HIGH compared CSS LOW , whereas the rate of MI was comparable for all 3 groups.
Multivariable Analysis
The results of the Cox multivariable analysis are shown in Table 4 . The log CSS, log SYNTAX Score, and log ACEF SCr score were all univariate predictors of long-term MACCE. After multivariate adjustment, the independent predictors of MACCE at 5-year follow-up were the log CSS and the presence of incomplete revascularization, diabetes, or peripheral vascular disease.
CSS Versus SYNTAX Score Versus ACEF SCr
The ROC curves for mortality and MACCE at 5-year follow-up are shown in Figure 2 . The respective C-statistics for the CSS, SYNTAX Score, and ACEF SCr score for 5-year mortality were 0.69, 0.62, and 0.65 and for 5-year MACCE were 0.62, 0.59, and 057 (PϽ0.05 for all).
CSS Versus MCRS Versus EURO ADD Versus EURO LOG
The Kaplan-Meier curves for 5-year mortality and MACCEfree survival stratified according to tertiles of the CSS, MCRS, EURO ADD , and EURO LOG are shown in Figure 3 . Overall, there were no significant differences between corresponding tertiles for the CSS, MCRS, EURO ADD , and EURO LOG . For each score, patient mortality and MACCE among those in the lowest tertile were significantly better than those in the highest tertile and comparable with the intermediate tertile. A significant difference in mortality was observed between the intermediate and highest tertile with the use of the MCRS and EURO ADD but not the EURO LOG or CSS. Conversely, the significant difference in MACCE between the intermediate and highest tertile observed with the CSS was not observed with the other 3 scores. The ROC curves for mortality and MACCE at 5-year follow-up for the CSS CrCl , CSS SCr , ACEF CrCl , ACEF SCr , SYNTAX score, MCRS, EURO ADD, EURO LOG , and SYNTAX score combined with the euroSCORE (additive and logistic) are shown in Figure 4 , and Table 5 .
The results of these analyses performed specifically in patients with 3VD can all be found in the online Data Supplement. 
Discussion
To the best of our knowledge, this is the first description of the CSS that represents a risk score combining both clinical and angiographic variables. The main findings from this study are that the CSS has an ability superior to either the SYNTAX Score or ACEF SCr score alone in the prediction of MACCE and mortality at 5-year follow-up in patients with complex CAD undergoing PCI. Furthermore, the log CSS is an independent predictor of long-term MACCE in this group of patients. Risk stratification and the assessment of risk-benefit are 2 important aspects of clinical medicine, 22 and should form an integral part of the patient informed consent process. Technological advances mean that the majority of coronary lesions are amendable to PCI; however, this may not always be the most appropriate treatment for an individual patient. The final decision of whether to perform PCI or CABG in patients with complex CAD is no longer simply based only on the views of the interventional cardiologist and cardiac surgeon; patient choice now plays an important part in the decision. Consequently, to enable patients to make the most appropriate informed decision for them as an individual, a suitable method of quantifying risk is essential. The importance of risk stratification in these patients is further emphasized when considering the escalating complexity of CAD being treated with PCI and the increasing age of patients undergoing PCI, 23 both of which are associated with less favorable clinical outcomes and greater procedural related morbidity. 24 Unfortunately, despite the unquestionable need, and in contrast to patients having CABG, few risk models have become established into regular clinical practice for patients undergoing PCI. The recently introduced SYNTAX Score offers the potential to meet this unmet clinical need. 1, 3 The SYNTAX Score is derived entirely from the coronary anatomy and lesion characteristics and is calculated using dedicated software, enabling complex coronary artery anatomy to be quantified. 6, 7 The score, which was an integral part of the SYNTAX trial design, 25 was initially devised as a method to ensure that both the cardiologist and cardiac surgeon accurately reviewed the angiogram of patients with complex CAD, enabling a consensus regarding the optimal method and completeness of revascularization to be reached. Importantly, the SYNTAX Score was calculated a priori, before the outcome of revascularization was known. The results of the SYNTAX trial have subsequently demonstrated that the score has an important role in stratifying patients with complex CAD to aid revascularization decisions. 1, 26 Further evaluation of the score has also indicated its ability to predict clinical outcomes. In patients with 3VD, the SYNTAX Score has been shown to be an independent predictor of MACCE at both 1-year 8 and 5-year follow-up. 10 Similarly, in patients with LMS disease, Capodanno et al 9 reported that the SYNTAX Score was able to predict both cardiac death (PϽ0.001) and MACCE (Pϭ0.04) at short-term follow-up. More recently, analysis of SYNTAX scores collected prospectively in the LEADERS study and retrospectively in the SIRTAX study indicates that risk stratification using the SYNTAX Score can be expanded to include all patients with CAD, irrespective of severity. 11, 27 The SYNTAX Score is independent of a patient's clinical characteristics, some of which, for example, patient age, have been consistently shown to be an independent predictor of mortality. 28 Furthermore, previous studies have demonstrated the superior performance of clinical based risk models, such as the MCRS, in the prediction of morbidity and mortality when compared with lesion-based scores such as the Amer- ican Heart Association lesion classification. 12 Therefore, the absence of any clinical characteristics in the calculation of the SYNTAX Score is a potential limitation to its use in risk stratification.
The CSS described in the present study for the first time represents a modification of the SYNTAX Score to accommodate for these inherent limitations. The present study has indicated that the inclusion of patient characteristics does improve the ability of the score, as indicated by the ROC curves, to predict MACCE and mortality compared with the original score. Intuitively, the use of multiple clinical variables should improve the accuracy of a risk model; however, this accuracy may ultimately be contaminated by the desire to create the "perfect model." 16 In practice, Ranucci et al 17 illustrated this by demonstrating that a simple scoring method using just age, LVEF, and SCr (ACEF SCr score) is as good as complex scores such as the euroSCORE (17 clinical variables) and Parsonnet score in predicting mortality in patients undergoing elective CABG. These 3 variables are known to affect the risk of both CABG 17 and PCI, 28 -30 and therefore even though the score has not previously been validated in patients undergoing PCI, it was considered acceptable to use as a basis for the development of the CSS. Retrospective justification for using the ACEF score as an integral part of the CSS come in part from the comparable C-statistics for MACCE and mortality between the validated MCRS and the ACEF CrCl (Table 5 , Figure 4 , and Supplementary Figure 2) . Of note, the combination of the SYNTAX score with the euroSCORE only offered an advantage over the CSS in the prediction of mortality among those patients with 2-and 3VD (Table 5 , Figure 4 , and Supplementary Figures 2 and 3) . The modification to the ACEF score to incorporate CrCl has also not previously been validated. Notably, in previous PCI studies that have identified renal dysfunction as a marker of adverse outcome either SCr or CrCl has been used, not both. 31, 32 Conversely, CrCl has been shown to be a better predictor when compared with SCr of risk in patients undergoing surgical revascularization. 18, 33 Incorporation of CrCl into the ACEF score can therefore be justified prospectively by extrapolation of these previous results and retrospectively by the improvements in the C-statistic for MACCE (0.60 versus 0.62) and mortality (0.67 versus 0.69) observed in this study when the CSS was calculated using the ACEF CrCl instead of ACEF SCr (Figure 4 and Table 5 ).
This study demonstrates a superior ability of the CSS to predict long-term MACCE and mortality when compared with the individual SYNTAX and ACEF scores. Importantly, after calculating the SYNTAX Score, which remains an important aid to deciding the appropriate revascularization strategy, the CSS can be derived quickly, using easily available variables that are not subject to any interobserver variability. The current analysis also indicates that whereas the CSS has a similar ability to predict mortality when compared with the MCRS and euroSCORE, it offers an additional advantage in the prediction of ischemic end points, which, as suggested by the C-statistics, are a somewhat harder end point to predict than mortality. Clearly, additional research is required to evaluate the potential of this new score in more diverse patient populations undergoing PCI.
Limitations
The current study is limited by its post hoc nature. In addition, the ROC method of analysis, although well suited for diagnostic purposes, may not be appropriate for prognostic models because these models must incorporate the dimension of time, which adds a stochastic element. 34 It has therefore been suggested that ROC analysis methods are not well validated for the assessment of time-censored data; however, in the current study the same methods have been used to assess both scoring systems, and these methods are consistent with previous published studies evaluating these risk models. 17 Other potential limitations include that lack of validation of the ACEF score in patients having PCI and the lack of any external validation in patients having either PCI or CABG. We accept that the current population may be too small to make definitive conclusions; however, at present, in view of its recent introduction, only select patient populations with complex disease have a SYNTAX score calculation and adjudicated long-term outcomes. The small sample size may account for the similar outcomes between low-and intermediate-risk groups when using the CSS, MCRS, EU-RO ADD , EURO LOG , SYNTAX-euroSCORE (logistic), and MCRS ( Figures 1 and 3 and Supplementary Figures 3 and 4) . It must also be acknowledged that there is a reduction in the predictive ability of the CSS when it is used in patients with 2VD and 3VD, as opposed to when it is used in only patients with 3VD. Importantly, however, this same observation is seen with both the established scores such as the MCRS and euroSCORE and the newer scores tested in this analysis (Table 5) .
Conclusion
An improvement in the ability of the SYNTAX Score to predict MACCE and mortality can be achieved by combining the SYNTAX Score with a simple clinical risk score incorporating age, ejection fraction, and creatinine clearance to produce the Clinical SYNTAX Score.
